Evidence map›Paper›PMID 36050642›Full record

ArticleBMC neurology2022

Adult-onset Still's disease with concurrent acute necrotizing encephalopathy: a case report.

Xue Yang, Meiling Wei, Shuguang Chu, Yue Zhang

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Xue Yang *Department of Rheumatology, Huashan Hospital, Fudan University, Shanghai, China.
Meiling Wei *Department of Neurology, Donglei Brain Hospital, Shanghai, China.
Shuguang Chu *Department of Radiology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
Yue ZhangDepartment of Neurology, Shanghai Huashan Hospital, Fudan University, Jing'an District, No. 12 Mid Urumqi Road, Shanghai, 200040, China. zygadene@163.com.ORCID http://orcid.org/0000-0002-1572-7910
Fudan University · CNShanghai East Hospital · CN

Funding

National Natural Science Foundation of China 81871277
6 · The paper itself

Abstract

backgroundAcute necrotizing encephalopathy (ANE) is a rare encephalopathy characterized by multiple symmetrical brain lesions, mainly involving thalami. Adult-onset Still's disease (AOSD) is a rare systemic inflammatory condition of unknown cause characterized by fever, sore throat, rash and joint pain. Both entities are considered to be triggered by infections and associated with hypercytokinemia. CASE PRESENTATION: A 46-year-old male was diagnosed with AOSD at local hospital because of 3-week-long high fever, sore throat, arthralgia, transient skin rash, lymphadenopathy, leukocytosis, hyperferritinemia, and absence of antinuclear antibodies (ANA) and rheumatoid factor (RF). Corticosteroids were not used because of delayed diagnosis. Three weeks after the onset, the patient suddenly fell unconscious and was transferred to our hospital. Brain CT and MRI revealed symmetrical lesions involving thalami, striatum and brain stem, consistent with ANE. One day after admission, his condition aggravated and brain CT revealed hemorrhage in the lesions. He died 3 days after admission.

conclusionWe report a rare case of ANE preceded by AOSD. The underlying mechanism is still unclear. Early recognizing of the two conditions is difficult but prognostically important.

Indexed as

Brain DiseasesPharyngitisStill's Disease, Adult-OnsetAdultArthralgiaFeverHumansLeukocytosisMaleMiddle AgedAcute necrotizing encephalitisAdult-onset Still’s diseaseComorbidityHemorrhage

Identifiers

PMID36050642
PMCPMC9438233
OpenAlexW4294025547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.